SBE enables sustainability for clinical-stage biotechnology companies by transferring a special kind of risk that occurs in therapeutic drug development into the capital markets. Our mission is to create and market innovative financing solutions that allow biotechnology companies to prevent and treat the most crucial unmet medical needs.
Looking for a particular Structured BioEquity SBE employee's phone or email?
The Structured BioEquity SBE annual revenue was $3 million in 2026.
Structured BioEquity SBE is based in New York, New York.
The NAICS codes for Structured BioEquity SBE are [32, 325, 32541, 3254].
The SIC codes for Structured BioEquity SBE are [28, 283].